Table of Contents

1 Market Overview

• 1.1 Objectives of Research
  • 1.1.1 Definition
  • 1.1.2 Specifications
• 1.2 Market Segment
  • 1.2.1 by Drug Type
    • 1.2.1.1 Lubiprostone
    • 1.2.1.2 Methyl Naltrexone Bromide
    • 1.2.1.3 Naldemedine
    • 1.2.1.4 Alvimopan
    • 1.2.1.5 Others
  • 1.2.2 by Application
    • 1.2.2.1 Hospital Pharmacies
    • 1.2.2.2 Retail Pharmacies
    • 1.2.2.3 Online Pharmacies
  • 1.2.3 by Regions

2 Industry Chain

• 2.1 Industry Chain Structure
• 2.2 Upstream
• 2.3 Market
  • 2.3.1 SWOT
  • 2.3.2 Dynamics

3 Environmental Analysis

• 3.1 Policy
• 3.2 Economic
• 3.3 Technology
• 3.4 Market Entry

4 Market Segmentation by Type

• 4.1 Market Size
  • 4.1.1 Lubiprostone Market, 2013-2018
  • 4.1.2 Methyl Naltrexone Bromide Market, 2013-2018
  • 4.1.3 Naldemedine Market, 2013-2018
  • 4.1.4 Alvimopan Market, 2013-2018
  • 4.1.5 Others Market, 2013-2018
• 4.2 Market Forecast
  • 4.2.1 Lubiprostone Market Forecast, 2019-2024
  • 4.2.2 Methyl Naltrexone Bromide Market Forecast, 2019-2024
  • 4.2.3 Naldemedine Market Forecast, 2019-2024
  • 4.2.4 Alvimopan Market Forecast, 2019-2024
  • 4.2.5 Others Market Forecast, 2019-2024

5 Market Segmentation by Application

• 5.1 Market Size
  • 5.1.1 Hospital Pharmacies Market, 2013-2018
  • 5.1.2 Retail Pharmacies Market, 2013-2018
  • 5.1.3 Online Pharmacies Market, 2013-2018
• 5.2 Market Forecast
  • 5.2.1 Hospital Pharmacies Market Forecast, 2019-2024
  • 5.2.2 Retail Pharmacies Market Forecast, 2019-2024
  • 5.2.3 Online Pharmacies Market Forecast, 2019-2024

6 Market Segmentation by Region

• 6.1 Market Size
  • 6.1.1 Asia-Pacific
    • 6.1.1.1 Asia-Pacific Market, 2012-2018
    • 6.1.1.2 Asia-Pacific Market by Type
    • 6.1.1.3 Asia-Pacific Market by Application
  • 6.1.2 North America
    • 6.1.2.1 North America Market, 2012-2018
    • 6.1.2.2 North America Market by Type
    • 6.1.2.3 North America Market by Application
  • 6.1.3 Europe
    • 6.1.3.1 Europe Market, 2012-2018
    • 6.1.3.2 Europe Market by Type
    • 6.1.3.3 Europe Market by Application
  • 6.1.4 South America
    • 6.1.4.1 South America Market, 2012-2018
    • 6.1.4.2 South America Market by Type
    • 6.1.4.3 South America Market by Application
  • 6.1.5 Middle East & Africa
    • 6.1.5.1 Middle East & Africa Market, 2012-2018
    • 6.1.5.2 Middle East & Africa Market by Type
    • 6.1.5.3 Middle East & Africa Market by Application
• 6.2 Market Forecast
  • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
  • 6.2.2 North America Market Forecast, 2019-2024
  • 6.2.3 Europe Market Forecast, 2019-2024
  • 6.2.4 South America Market Forecast, 2019-2024
  • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 Market Competitive

• 7.1 Global Market by Vendors
• 7.2 Market Concentration
• 7.3 Price & Factors
• 7.4 Marketing Channel

8 Major Vendors

• 8.1 Ironwood Pharmaceuticals Inc
• 8.2 Daiichi Sankyo Co Ltd
• 8.3 Pfizer
• 8.4 Progenics Pharmaceuticals Inc
• 8.5 Shionogi & Co., Ltd
• 8.6 Allergan Plc
• 8.7 Nektar Therapeutics
• 8.8 Purdue Pharma
• 8.9 S.L.A. Pharma AG
• 8.10 Mundipharma International Limited
• 8.11 Ono Pharmaceutical Co., Ltd
• 8.12 Takeda Pharmaceutical Company Limited
• 8.13 Theravance Biopharma Inc
• 8.14 Valeant Pharmaceuticals International
• 8.15 Cosmo Pharmaceuticals SA
• 8.16 Daewoong Pharmaceutical
• 8.17 C.B. Fleet Company
• 8.18 Sucampo Pharmaceuticals

9 Conclusion

Summary
The global Opioid Induced Constipation (OIC) Drugs market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on Drug Type, the report describes major products type share of regional market. Products mentioned as follows:
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Valeant Pharmaceuticals International
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa